Diagnostic performance and costs of Capilia TB for Mycobacterium tuberculosis complex identification from broth‐based culture in Bangkok, Thailand

Tropical Medicine and International Health - Tập 14 Số 7 - Trang 748-753 - 2009
Keerataya Ngamlert1, Chalinthorn Sinthuwattanawibool2, Kimberly D. McCarthy3, Hojoon Sohn4, Angela M. Starks3, Photjanart Kanjanamongkolsiri1, Rapeepan Anekvorapong1, Theerawit Tasaneeyapan2, Patama Monkongdee2, Lois Diem3, Jay K. Varma3,2
1Health Laboratory Division (City Lab), Health Department, Bangkok Metropolitan Administration, Thailand
2Thailand Ministry of Public Health – US CDC Collaboration, Tuberculosis program, Nonthaburi, Thailand
3Division of Tuberculosis Elimination, US Centers for Disease Control and Prevention, Atlanta, GA, USA
4Independent consultant, Daegu, Republic of Korea

Tóm tắt

SummaryObjectives  Broth‐based culture (BBC) systems are increasingly being used to detect Mycobacterium tuberculosis complex (MTBC) in resource‐limited. We evaluated the performance, time to detection and cost of the Capilia TB identification test from broth cultures positive for acid‐fast bacilli (AFB) in Thailand.Methods  From October–December 2007, broth cultures that grew AFB from specimens submitted by district TB clinics to the Bangkok city laboratory were tested for MTBC using Capilia TB and standard biochemical tests. Isolates that were identified as MTBC by biochemical tests but not by Capilia TB underwent repeat testing using Capilia TB, Accuprobe (Gen‐Probe, San Diego, CA, USA) and sequencing. Costs of time, labour, infrastructure and consumables for all procedures were measured.Results  Of 247 isolates evaluated, the sensitivity of Capilia TB was 97% and its true specificity 100% compared with biochemical testing. The median time from specimen receipt to confirmed MTBC identification was 20 days (range 7–53 days) for Capilia TB and 45 days (range 35–79 days) for biochemical testing (P < 0.01). Six isolates that were Capilia TB negative but positive by biochemical testing were confirmed as MTBC and mutations in the mpb64 gene were detected in all. The unit cost of using Capilia TB was 2.67 USD that of biochemical testing was 8.78 USD.Conclusions  In Thailand, Capilia TB had acceptable sensitivity and specificity, was lower in cost and had shorter turn‐around times. Laboratories investing in BBC should consider Capilia TB for identification of MTBC, after validation of performance in their setting.

Từ khóa


Tài liệu tham khảo

Abe C, 1999, Simple and rapid identification of the Mycobacterium tuberculosis complex by immunochromatographic assay using anti‐mpb64 monoclonal antibodies, Journal of Clinical Microbiology, 37, 3693, 10.1128/JCM.37.11.3693-3697.1999

Chien HP, 2000, Comparison of the BACTEC MGIT 960 with Lowenstein–Jensen medium for recovery of mycobacteria from clinical specimens, International Journal of Tuberculosis Lung Diseases, 4, 866

10.1128/JCM.42.1.474-477.2004

10.1128/JCM.43.2.688-695.2005

Drummond MF, 1997, Methods for the Economic Evaluation of Health Care Programmes

10.1128/JCM.40.3.908-912.2002

10.11150/kansenshogakuzasshi1970.77.110

Hillemann D, 2005, Application of the Capilia TB assay for culture confirmation of Mycobacterium tuberculosis complex isolates, International Journal of Tuberculosis Lung Diseases, 9, 1409

10.1128/JCM.42.1.390-392.2004

Kent P, 1985, Public Health Mycobacteriology: Guide for the Level III Laboratory

Nagai S, 1991, Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis, Infection and Immunity, 59, 372, 10.1128/iai.59.1.372-382.1991

10.1586/14737159.6.3.423

10.1007/s100960050275

10.1086/518656

10.1016/j.diagmicrobio.2008.02.015

Stop TB, 2007, Seventh Meeting. Strategic and Technical Advisory Group for Tuberculosis (STAG‐TB) Report on Conclusions and Recommendations

Tan‐Torres ET, 2003, Making Choices in Health: WHO Guide to Cost‐effectiveness Analysis

10.1016/j.diagmicrobio.2007.06.010

WHO, 1998, Laboratory Services in Tuberculosis Control. Culture Part III

WHO, 2007, The Global MDR‐TB and XDR‐TB Response Plan

Thông tin
Thông tin xuất bản

Tropical Medicine and International Health

Tập 14 Số 7

748-753

Thông tin tác giả